Narges Dastmalchi

648 total citations
41 papers, 482 citations indexed

About

Narges Dastmalchi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Narges Dastmalchi has authored 41 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 23 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Narges Dastmalchi's work include Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (14 papers) and Circular RNAs in diseases (10 papers). Narges Dastmalchi is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (14 papers) and Circular RNAs in diseases (10 papers). Narges Dastmalchi collaborates with scholars based in Iran, Iraq and New Zealand. Narges Dastmalchi's co-authors include Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, Mohammad Ali Hosseinpour Feizi, Behzad Baradaran, Saeid Latifi‐Navid, Mahdi Abdoli Shadbad, Bashdar Mahmud Hussen, Amir Baghbanzadeh, Behzad Baradaran and Khalil Hajiasgharzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Life Sciences.

In The Last Decade

Narges Dastmalchi

38 papers receiving 479 citations

Peers

Narges Dastmalchi
Shuai Jin China
Sisi Wei China
Airong Wu China
Narges Dastmalchi
Citations per year, relative to Narges Dastmalchi Narges Dastmalchi (= 1×) peers Nooshin Shabab

Countries citing papers authored by Narges Dastmalchi

Since Specialization
Citations

This map shows the geographic impact of Narges Dastmalchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narges Dastmalchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narges Dastmalchi more than expected).

Fields of papers citing papers by Narges Dastmalchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narges Dastmalchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narges Dastmalchi. The network helps show where Narges Dastmalchi may publish in the future.

Co-authorship network of co-authors of Narges Dastmalchi

This figure shows the co-authorship network connecting the top 25 collaborators of Narges Dastmalchi. A scholar is included among the top collaborators of Narges Dastmalchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narges Dastmalchi. Narges Dastmalchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Dastmalchi, Narges, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.. (2022). The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagy. Molecular Biology Reports. 49(9). 8325–8335. 9 indexed citations
4.
Safaralizadeh, Reza, et al.. (2022). Epigenetic-related Effects of COVID-19 on Human Cells. Infectious Disorders - Drug Targets. 22(7). 21–26. 1 indexed citations
5.
Dastmalchi, Narges, Reza Safaralizadeh, Mohammad Ali Hosseinpour Feizi, Behzad Baradaran, & Seyed Mahdi Banan Khojasteh. (2021). MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Molecular Biology Reports. 48(2). 1345–1357. 26 indexed citations
6.
Safaralizadeh, Reza, et al.. (2021). Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues. Journal of Gastrointestinal Cancer. 53(4). 990–994. 7 indexed citations
7.
Dastmalchi, Narges, et al.. (2021). PVT1 and ZFAS1 lncRNAs expressions and their biomarker value in gastric cancer tissue sampling among Iranian population. Molecular Biology Reports. 48(11). 7171–7177. 11 indexed citations
8.
Dastmalchi, Narges, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.. (2021). The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer. Medical Oncology. 39(1). 9–9. 3 indexed citations
9.
Hussen, Bashdar Mahmud, et al.. (2021). Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. International Immunopharmacology. 96. 107765–107765. 60 indexed citations
10.
Dastmalchi, Narges, et al.. (2021). An Updated Review of the Pre-Clinical Role of microRNAs and theirContribution to Colorectal Cancer. Current Molecular Medicine. 22(10). 851–859. 2 indexed citations
11.
Dastmalchi, Narges, Behzad Baradaran, Saeid Latifi‐Navid, et al.. (2020). Antioxidants with two faces toward cancer. Life Sciences. 378. 118186–118186. 34 indexed citations
12.
Dastmalchi, Narges, Mohammad Ali Hosseinpour Feizi, Seyed Mahdi Banan Khojasteh, Behzad Baradaran, & Reza Safaralizadeh. (2020). Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sciences. 259. 118239–118239. 71 indexed citations
13.
Baradaran, Behzad, Mohammad Ali Hosseinpour Feizi, Narges Dastmalchi, et al.. (2020). BC032913 as a Novel Antisense Non-coding RNA is Downregulated in Gastric Cancer. Journal of Gastrointestinal Cancer. 52(3). 928–931. 11 indexed citations
14.
Baradaran, Behzad, et al.. (2020). The Correlation Between Helicobacter pylori Infection and Lnc-OC1 Expression in Gastric Cancer Tissues in an Iranian Population. Journal of Gastrointestinal Cancer. 52(2). 600–605. 8 indexed citations
15.
Dastmalchi, Narges, Reza Safaralizadeh, Behzad Baradaran, Mohammad Ali Hosseinpour Feizi, & Amir Baghbanzadeh. (2019). An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer. Gene. 729. 144301–144301. 33 indexed citations
16.
Pouladi, Nasser, et al.. (2018). Association of P53 (+16ins-Arg) Haplotype with the Increased Susceptibility to Breast Cancer in Iranian-Azeri Women. SHILAP Revista de lepidopterología. 25(1). 9–17. 2 indexed citations
17.
Safaralizadeh, Reza, et al.. (2018). Investigation of the changes in the expression levels of MOZ gene in colorectal cancer tissues. Journal of Gastrointestinal Oncology. 10(1). 68–73. 4 indexed citations
18.
Feizi, Mohammad Ali Hosseinpour, et al.. (2017). Evaluation of the Five Year-Survival Rate in Breast Cancer Patients of East Azarbaijan Province. Journal of Advances in Medical and Biomedical Research. 25(112). 30–39. 1 indexed citations
19.
Feizi, Mohammad Ali Hosseinpour, et al.. (2017). Association of FAS Gene Polymorphism(-1378G>A) with Risk of Breast Cancer in Northwestern Iran. journal of ilam university of medical sciences. 24(6). 117–126. 1 indexed citations
20.
Safaralizadeh, Reza, Narges Dastmalchi, Mohammad Ali Hosseinpour Feizi, & Saeid Latifi‐Navid. (2017). Helicobacter pylori virulence factors in relation to gastrointestinal diseases in Iran. Microbial Pathogenesis. 105. 211–217. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026